Madrigal Announces New Clinical Data Demonstrating Rezdiffra (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the…
Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
Ad hoc announcement pursuant to Art. 53 LR Net sales grew +15%…
Cyble Wins 22 Badges in G2 Spring 2025 Report Across Multiple Cybersecurity Categories
CUPERTINO, Calif. and MUMBAI, India, April 8, 2025 /PRNewswire/ -- Cyble, a…
Kia EV3 named as Top Three vehicle in multiple categories in 2025 World Car Awards
Kia EV3 recognized in World Car Design of the Year, World Electric…
Hexaware Triumphs at World HRD Congress 2025 with Multiple Accolades
MUMBAI, India, March 18, 2025 /PRNewswire/ -- Hexaware Technologies, a leading global…
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
ANN ARBOR, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc.,…
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
Sarclisa is the first anti-CD38 treatment approved in China for patients with…
Dynex Honored with Multiple Renowned Awards and Nominations, Showcasing Leadership in Quantum Computing
Dynex recognitions as a winner of the BIG Innovation Award 2025 and…
Abracon Unveils Multiple Lines of Innovative MEMs Oscillators to Electronics Market
SPICEWOOD, Texas, Jan. 22, 2025 /PRNewswire/ -- Abracon, a leading provider of…
UPDATE – NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or…